Search Ontology:
ChEBI
zavegepant
- Term ID
- CHEBI:229643
- Synonyms
-
- (R)-N-(3-(7-methyl-1H-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)piperazin-1-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide
- BHV 3500
- BHV-3500
- BHV3500
- BMS 742413
- BMS-742413
- BMS-742413-01
- N-{(2R)-3-(7-methyl-1H-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl}-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide
- zavegepant
- zavegepantum
- Definition
- A member of the class of ureas that is urea in which both amino groups are replaced by 4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidin-1-yl and {(2R)-3-(7-methyl-1H-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl}amino groups. It is a calcitonin gene-related peptide receptor antagonist whose hydrochloride salt has been approved by the FDA for the acute treatment of migraine.
- References
-
- CAS:1337918-83-8
- DrugBank:DB15688
- KEGG:D11898
- PMID:23632269
- PMID:33096162
- PMID:35774914
- PMID:36189708
- PMID:36239038
- PMID:36552072
- PMID:36804093
- PMID:37012363
- PMID:37094060
- PMID:37227596
- PMID:37270693
- PMID:37345774
- PMID:37363553
- PMID:37593294
- PMID:37630989
- PMID:37723470
- PMID:37897226
- PMID:37904462
- PMID:38311738
- PMID:38333255
- Patent:US2012059017
- Wikipedia:Zavegepant
- Ontology
- ChEBI ( EBI )
- is a type of
- has_role
-
- inverse is_conjugate_acid_of
-
- is_conjugate_base_of
-
Phenotype
Phenotype resulting from zavegepant
Phenotype where environments contain zavegepant
Phenotype modified by environments containing zavegepant
Human Disease Model